A Clinical Update on MASLD
This Clinical Insights discusses new diagnostic criteria, risk stratification, and emerging treatments of metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease).
Related Articles
Clinical guideline highlights for the hospitalist: International consensus criteria for pediatric sepsis and septic shock
Click on the article title to read more.
Police departments across U.S. are starting to use artificial intelligence to write crime reports
Even as AI gains traction in police work, legal experts are raising concerns over accuracy, transparency, and potential bias.
What’s the Difference Between Walking Pneumonia and Regular Pneumonia?
Walking pneumonia may be milder than traditional pneumonia, but it can still pack a wallop. A pulmonologist explains the differences in causes, symptoms and treatment.
Can Antipsychotics Increase Mortality Risk? A New Study Shows It Might
A study showed high-dose antipsychotics and benzodiazepines were linked to an increased mortality risk for those with schizophrenia. High-dose antidepressants lowered the risk.
U.S. National Trends and Disparities in Suicidal Ideation, Suicide Attempts, and Health Care Use
To better understand the trends and disparities in suicidal thoughts and behaviors among demographic subgroups, The Pew Charitable Trusts worked with Dr. Hillary Samples to…
Selective autophagy impedes KSHV entry after recruiting the membrane damage sensor galectin-8 to virus-containing endosomes
Kaposi sarcoma-associated herpesvirus (KSHV) is associated with endothelial, osteoblastic, and B cell tumors. Schmidt et al. demonstrate that autophagy restricts KSHV during entry. Interaction of the…
Changing a single number among billions can destroy an AI model
Today’s huge AI models are composed of several billion numbers known as weights and changing just one of them can destroy their ability to function,…
Recordati investor CVC taps up potential buyers of drugs group, rival says
The main shareholder of Italy’s Recordati is in contact with other Italian drugmakers over a possible sale, the chief executive of rival Dompe Farmaceutica told…
Weight Loss With Amgen Drug in Line With Eli Lilly Med, But Dosing Could Be Differentiator – MedCity News
Amgen’s experimental obesity drug, MariTide, led to an average 20% reduction in weight in a Phase 2 clinical trial. While investors hoped for greater weight…
Cortechs.ai Announces Oversubscribed Funding Round to Accelerate Innovation in AI-Powered Neuroimaging and Oncology Solutions
/PRNewswire/ — Cortechs.ai, a leader in AI-powered neuroimaging and prostate imaging solutions, is pleased to announce the successful close of an…
